Related Experiment Video

Updated: Jun 8, 2026

Non-Destructive Evaluation of Regional Cell Density Within Tumor Aggregates Following Drug Treatment
10:13

Non-Destructive Evaluation of Regional Cell Density Within Tumor Aggregates Following Drug Treatment

Published on: June 21, 2022

Activity of trabectidin in desmoplastic small round cell tumor

Ana López-González1, Blanca Cantos, Eva Tejerina

  • 1Medical Oncology, Hospital Universitario Puerta de Hierro, Madrid, Spain.

Medical Oncology (Northwood, London, England)
|October 7, 2010
PubMed

Insights

Desmoplastic small round cell tumor (DSRCT) is a rare cancer. Trabectedin showed antitumoral activity in a patient refractory to other treatments, offering new hope.

Area of Science:

  • Oncology
  • Medical Research

Background:

  • Desmoplastic small round cell tumor (DSRCT) is an aggressive malignancy predominantly affecting adolescent males.
  • Limited research exists on DSRCT treatment efficacy and survival outcomes due to its rarity.

Observation:

  • A case study involving a patient with DSRCT who demonstrated resistance to multiple chemotherapeutic agents.

Findings:

  • The patient achieved disease stability with trabectedin treatment.
  • This case provides the first reported evidence of trabectedin's antitumoral effects in DSRCT.

Implications:

  • Trabectedin may represent a potential therapeutic option for DSRCT patients resistant to standard therapies.
  • Further investigation into trabectedin's efficacy in DSRCT is warranted to improve patient survival rates.

More Related Videos

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization09:49

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Published on: December 2, 2013

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...